High levels of PD-1 or AFAP1-AS1 in tumor-infiltrating lymphocytes are linked to poor patient prognosis, whereas simultaneous expression of both AFAP1-AS1 and PD-1 is linked to the lowest survival rate [98]. Here, PDCD1 is linked to neoplasm.